Project Grant R03AG095709
- The National Institute on Aging awarded Mayo Clinic $729,906 on September 3, 2026, under the Aging Research program (CFDA 93.866) to investigate the neurobiological substrates of falls in cognitively unimpaired older adults. The research uses dual-task paradigms that simultaneously engage motor and cognitive brain systems to characterize subclinical gait impairment patterns among cognitively unimpaired individuals who experience falls. The study assesses how gait impairment relates to...
- The National Institute on Aging awarded Hebrew Rehabilitation Center (doing business as Hebrew Senior Life) $729,000 on September 10, 2025, under the Aging Research program (CFDA 93.866) to adapt and pilot an Integrated Care for Older Persons (ICOPE) protocol for post-acute skilled nursing facilities. The project will adapt existing community-based ICOPE protocols to align with skilled nursing facility workflows through semi-structured interviews with SNF staff, then test the adapted protocol in...
- The National Institute on Aging awarded Aster Labs, Inc. $499,943 on September 15, 2025, under the Aging Research program (CFDA 93.866) to design and construct a wearable gait-monitoring device for continuous home-based assessment of health decline in Black adults with Alzheimer's disease and related dementias. The device will measure gait patterns including stride and speed throughout the day to provide clinicians and caregivers with early indication of functional decline and disease...
- The National Institute on Aging awarded $691,763 to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab) on August 1, 2026, under the Aging Research program (CFDA 93.866) to evaluate the effectiveness of a wearable hip airbag equipped with a stroke-specific pre-impact fall detection algorithm in older adults with stroke. The project will assess whether the wearable airbag accurately deploys during falls, reduces hip injuries, decreases fear of falling, and...
- The National Institute on Aging awarded the University of North Carolina at Chapel Hill $642,030 through the Aging Research program (CFDA 93.866) on September 1, 2026, to conduct a multi-site, blinded, randomized controlled trial evaluating a wearable ankle power training intervention with push-off biofeedback to improve gait performance and walking function in older adults. The award funds a four-year project (through August 31, 2030) examining the efficacy of smart passive ankle resistance...
- The National Institute on Aging awarded Hebrew Rehabilitation Center $437,250 on July 15, 2026, under the Aging Research program (CFDA 93.866) to validate the Healthcare Effectiveness Data and Information Set (HEDIS) frailty definition against clinical frailty assessments and evaluate its impact on Medicare Advantage Star Ratings for cancer screening quality metrics. The research will determine the accuracy of the current HEDIS frailty definition—which relies on unvalidated diagnosis and...
- The National Institute on Aging awarded Education Development Center, Inc. $320,150 under the Aging Research program (CFDA 93.866) on September 1, 2026. The research project examines elder mistreatment and self-neglect among older adults with Alzheimer's disease and related dementias, leveraging the UCLA Alzheimer's and Dementia Care (ADC) Program's longitudinal dataset of structured data and clinical notes from dementia care specialists. The study expands the existing dataset to include three...
- The National Institute on Aging awarded Colorado State University $231,000 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a pilot clinical trial assessing the feasibility, acceptability, and efficacy signal of a real-life dual-task training intervention for older adults at risk of falling. The study compares a six-week real-life dual-task training intervention (REAL-DTT) with an evidence-based fall prevention intervention (FallStalk). REAL-DTT delivers...
- The National Institute on Aging awarded Brigham & Women's Hospital Inc. $943,368 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate health care contact days—days older adults spend obtaining health care outside the home—and their impact on patient outcomes. The research addresses three primary aims. Aim 1 employs semi-structured interviews and focus groups across two large health systems serving multiple populations in five states to elicit perspectives...
- The National Institute on Aging awarded The MGH Institute of Health Professions, Inc., $624,208 on June 1, 2026, under the Aging Research program (CFDA 93.866) to investigate cerebral microvascular hemodynamics and speech motor control in adults at genetic risk for Alzheimer's disease. The recipient will collect noninvasive magnetic resonance imaging data and detailed speech samples from a cohort of older adults aged 60–80 stratified by apolipoprotein E E4 status. Microvascular physiology will...
The National Institute on Aging awarded Hebrew Rehabilitation Center $318,000 on August 18, 2026, under the Aging Research program (CFDA 93.866) to conduct a pilot study of home-based dual-task gait assessment in older adults at risk of dementia. The project will recruit 60 ambulatory adults aged 65 and older—30 with mild cognitive impairment and 30 age- and sex-matched controls—to use a smartphone-based gait application for daily assessments in their homes over a two-week baseline period, followed by weekly assessments for one year. Participants will complete comprehensive lab-based functional assessments evaluating health history, cognitive function, mobility, and factors influencing gait, and will report falls and injuries via the application. Follow-up phone interviews will occur when falls are reported. The study addresses the elevated fall risk in older adults with mild cognitive impairment, which accelerates cognitive decline and increases risk of Alzheimer's disease and related dementias. Existing clinical gait assessments conducted annually in clinical settings fail to capture real-time changes signaling acute increases in fall likelihood. Two specific aims will quantify day-to-day variation in normal and dual-task gait performance (walking while performing verbalized serial subtractions) during the baseline period and then track gait performance changes over the following year to identify patterns associated with acute fall risk. Work is performed in Roslindale, Massachusetts. The period of performance runs from August 18, 2026, through July 31, 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $318.0k | 8/18/26 |